BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioMidwest

  MicroBiome Therapeutics LLC’ NM504 Improves Blood Glucose Control In Diabetes And Prediabetes

  June 23, 2014

   · 

  4 min read
• Deals

  Shire plc Release: Management Spurns Three Offers From AbbVie , Fighting For Irish Independence, Call Monday Morning

  June 23, 2014

   · 

  1 min read
• Biotech Beach

  Immudex Selects CryoPort, Inc. To Manage Cold Chain Logistics Of Biologic Samples And Proficiency Panels Worldwide

  June 23, 2014

   · 

  4 min read
• Drug Development

  IP Group Plc – Portfolio Company Diurnal Reports Positive Phase 2 Results

  June 23, 2014

   · 

  8 min read
• Genetown

  Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant

  June 23, 2014

   · 

  4 min read
• Business

  Russell Katz Appointed U.S. Account Manager Of m2p-labs

  June 23, 2014

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Announces Initiation Of A Phase 2 Clinical Trial Of XP23829 In Patients With Psoriasis

  June 23, 2014

   · 

  1 min read
• Drug Development

  Trevena, Inc. Announces Positive Phase 1 Results For TRV734 For Acute And Chronic Pain

  June 23, 2014

   · 

  1 min read
• Business

  T23 Announces Global License Of The Scripps Research Institute’ CD22 Siglec Oncoimmunological Platform For B-Cell Tumors

  June 23, 2014

   · 

  3 min read
• Drug Development

  Clovis Oncology Announces First Patient Enrolled In TIGER2 Study

  June 23, 2014

   · 

  1 min read